Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of Pituitary adenomas: a cross-sectional study in the Province of Liège, Belgium. J Clin Endocrinol Metabolism 91(12):4769–4775. https://doi.org/10.1210/jc.2006-1668

Article  CAS  Google Scholar 

Ferrante E, Ferraroni M, Castrignanò T, Menicatti L, Anagni M, Reimondo G, Del Monte P, Bernasconi D, Loli P, Faustini-Fustini M, Borretta G, Terzolo M, Losa M, Morabito A, Spada A, Beck-Peccoz P, Lania AG (2006) Non-functioning Pituitary Adenoma database: a useful resource to improve the Clinical Management of Pituitary tumors. eur j Endocrinol 155(6):823–829. https://doi.org/10.1530/eje.1.02298

Article  CAS  PubMed  Google Scholar 

Molitch ME, Pituitary, Incidentalomas (2009) Best Pract Res Clin Endocrinol Metab 23(5):667–675. https://doi.org/10.1016/j.beem.2009.05.001

Article  CAS  PubMed  Google Scholar 

Huang W, Molitch ME (2018) Management of nonfunctioning pituitary adenomas (NFAs): Observation. Pituitary 21(2):162–167. https://doi.org/10.1007/s11102-017-0856-0

Article  PubMed  Google Scholar 

Yavropoulou MP, Tsoli M, Barkas K, Kaltsas G, Grossman A (2020) The natural history and treatment of non-functioning Pituitary Adenomas (Non-functioning PitNETs). Endocrine-related Cancer 27(10):R375–R390. https://doi.org/10.1530/ERC-20-0136

Article  CAS  PubMed  Google Scholar 

Molitch ME (2014) Nonfunctioning pituitary tumors. In handbook of clinical neurology. Elsevier 124:167–184. https://doi.org/10.1016/B978-0-444-59602-4.00012-5

Article  Google Scholar 

Greenman Y, Stern N (2015) Optimal management of non-functioning pituitary adenomas. Endocrine 50(1):51–55. https://doi.org/10.1007/s12020-015-0685-8

Article  CAS  PubMed  Google Scholar 

Greenman Y, Cooper O, Yaish I, Robenshtok E, Sagiv N, Jonas-Kimchi T, Yuan X, Gertych A, Shimon I, Ram Z, Melmed S, Stern N (2016) Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists. Eur J Endocrinol 175(1):63–72. https://doi.org/10.1530/EJE-16-0206

Article  CAS  PubMed  Google Scholar 

Dekkers OM, Hammer S, de Keizer RJW, Roelfsema F, Schutte PJ, Smit JWA, Romijn JA, Pereira AM (2007) The natural course of non-functioning Pituitary Macroadenomas. eur j Endocrinol 156(2):217–224. https://doi.org/10.1530/eje.1.02334

Article  CAS  PubMed  Google Scholar 

Lenders N, Ikeuchi S, Russell AW, Ho KK, Prins JB, Inder WJ (2016) Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas. Clin Endocrinol 84(2):222–228. https://doi.org/10.1111/cen.12879

Article  CAS  Google Scholar 

Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S, Wass JAH (2007) What is the natural history of Nonoperated Nonfunctioning Pituitary Adenomas? Clin Endocrinol 67(6):938–943. https://doi.org/10.1111/j.1365-2265.2007.02990.x

Article  CAS  Google Scholar 

Ayalon-Dangur I, Robenshtok E, Duskin‐Bitan H, Tsvetov G, Gorshtein A, Akirov A, Shimon I (2023) Natural history of nonfunctioning Pituitary macroadenomas followed without intervention: a retrospective cohort study. Clin Endocrinol 98(4):559–566. https://doi.org/10.1111/cen.14877

Article  CAS  Google Scholar 

Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, de Ponce PG, Erwin PJ, Carey J, Montori VM (2011) Natural history of nonfunctioning Pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metabolism 96(4):905–912. https://doi.org/10.1210/jc.2010-1054

Article  CAS  Google Scholar 

Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW, Fernández-Balsells MM, Bagatto A, Coto-Yglesias F, Carey J, Elraiyah TA, Erwin PJ, Gandhi GY, Montori VM, Murad MH (2012) Treatment of hyperprolactinemia: a systematic review and Meta-analysis. Syst Rev 1(1):33. https://doi.org/10.1186/2046-4053-1-33

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vieira Neto L, Wildemberg LE, Moraes AB, Colli LM, Kasuki L, Marques NV, Gasparetto EL, de Castro M, Takiya CM, Gadelha MR (2015) Dopamine receptor subtype 2 expression Profile in Nonfunctioning Pituitary adenomas and in vivo response to Cabergoline Therapy. Clin Endocrinol 82(5):739–746. https://doi.org/10.1111/cen.12684

Article  CAS  Google Scholar 

Batista RL, Musolino NRC, Cescato VAS, da Silva GO, Medeiros RSS, Herkenhoff CGB, Trarbach EB, Cunha-Neto (2019) M. B. Cabergoline in the management of residual nonfunctioning pituitary adenoma: a Single-Center, Open-Label, 2-Year randomized clinical trial. Am J Clin Oncol 42(2):221–227. https://doi.org/10.1097/COC.0000000000000505

Article  CAS  PubMed  Google Scholar 

Vargas-Ortega G, González-Virla B, Balcázar-Hernández L, Arreola-Rosales R, Benitez-Rodríguez FJ, Félix BL, Mercado M (2022) Efficacy of Cabergoline Therapy in patients with non-functioning pituitary adenomas: a single Center Clinical Experience. Archives of Endocrinology and Metabolism. https://doi.org/10.20945/2359-3997000000495

Article  PubMed  PubMed Central  Google Scholar 

Garcia EC, Naves LA, Silva AO, de Castro LF, Casulari LA, Azevedo MF (2013) Short-term treatment with Cabergoline Can lead to Tumor Shrinkage in patients with nonfunctioning pituitary adenomas. Pituitary 16(2):189–194. https://doi.org/10.1007/s11102-012-0403-y

Article  CAS  PubMed  Google Scholar 

Ertekin T, Acer N, Turgut AT, Aycan K, Ozçelik O, Turgut M (2011) Comparison of three methods for the estimation of the Pituitary gland volume using magnetic resonance imaging: a Stereological Study. Pituitary 14(1):31–38. https://doi.org/10.1007/s11102-010-0254-3

Article  PubMed  Google Scholar